Nyaditum Resae
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nyaditum Resae, covering 2017-09-07 to 2025-05-16. Get the full timeline:
Most recent: Clinical Trial Update: Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota [NA]